Dr. Shauly
Research
Devices
Digital Curbside
Innovation
Podcast
About
Contact

Dr. Orr Shauly

Plastic & Reconstructive Surgery

ResearchDevicesDigital CurbsideInnovationPodcastAboutContact

© 2026 Dr. Orr Shauly

LinkedInInstagramX / Twitter
← All publications

December 2024

Growth In FDA-Approved AI Devices In Plastic Surgery: A Key Look Into The Future

Plastic surgery has recently seen a significant rise in the adoption of artificial intelligence (AI) and machine learning (ML), aligning with broader trends across the medical field.

Why this matters

Plastic surgery has recently seen a significant rise in the adoption of artificial intelligence (AI) and machine learning (ML), aligning with broader trends across the medical field. This work contributes to evidence-based plastic and reconstructive surgery — helping clinicians interpret outcomes, refine technique, and counsel patients with clearer data.

Author

Dr. Orr Shauly

Plastic and reconstructive surgery resident at Emory University (UCLA BS, USC MD) with an h-index of 15 and peer-reviewed work spanning aesthetic surgery, reconstruction, medical devices, and AI in medicine.

AboutAll researchRequest full text →

Abstract

Plastic surgery has recently seen a significant rise in the adoption of artificial intelligence (AI) and machine learning (ML), aligning with broader trends across the medical field. These technologies aim to enhance surgical efficiency, optimize treatment planning, predict post-surgical aesthetic results, streamline patient management, and improve overall surgical decision-making. However, the integration of AI/ML into clinical practice presents ethical and practical challenges, including concerns about transparency, data bias, and security. The regulation and approval of AI/ML technologies, much like other medical devices, remain complex and continuously evolving. The US FDA has been proactive in addressing these challenges, developing specific frameworks for AI- and/or ML-based devices.

Read full articleRequest full text